reference/14033372

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/14033372

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	1679
issn	0007-0920 1532-1827
issueIdentifier	11
pageRange	1675-1679
publicationName	British Journal of Cancer
startingPage	1675
bibliographicCitation	Waddell T, Kotsori A, Constantinidou A, Yousaf N, Ashley S, Parton M, Allen M, Starling N, Papadopoulos P, O'Brien M, Smith I, Johnston S. Trastuzumab beyond progression in HER2-positive advanced breast cancer: The Royal Marsden experience. British Journal of Cancer. 2011 Apr 26;104(11):1675–9. doi: 10.1038/bjc.2011.138.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_768bcb55f943194f50a54eebf9662cda http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3b3e4715f7f20a8c4935b76996a17408 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8773a8ed68e7927b18c778d90196db1d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d101b0a913017c471ff94f1b0b1b0687 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_042ac53e9454a301f33e8a3311cda359 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e05fa9b423e792860ab6df780f4f5fa0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5f2bf9f18656c90a6ea2a0907866bcbe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_61db57d311956620d85f4b3125da3c5c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_97fa97b18f28b4a2d49780ce176a817d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_36168b9925c37109f0b19f9f0a84065f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_651d47ca3a73b801110ecdc592ac313e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6f90a21cc93cf41d9c8900e68f8a1c29
date	2011-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC3111155 https://doi.org/10.1038/bjc.2011.138 https://pubmed.ncbi.nlm.nih.gov/21522147
isPartOf	https://portal.issn.org/resource/ISSN/0007-0920 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1765 https://portal.issn.org/resource/ISSN/1532-1827
language	English
source	https://www.crossref.org/ https://scigraph.springernature.com/ https://pubmed.ncbi.nlm.nih.gov/
title	Trastuzumab beyond progression in HER2-positive advanced breast cancer: The Royal Marsden experience
discusses	http://id.nlm.nih.gov/mesh/M0556300 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0001357 http://id.nlm.nih.gov/mesh/M0291428
hasSubjectTerm	http://purl.org/au-research/vocabulary/anzsrc-for/2008/11 http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9d7fe60f25abdf582afc7cdca238bde8 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7ed75134b36b0e173fb44798462e4e66 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6890 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e8ad08f759b2798c1b5dca78861cc6ce http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_43830973f74de180729ad1e755d592ad

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127494626 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID245740308 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136123131 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127925204

Total number of triples: 51.